第14届日本生物分析论坛研讨会的亮点
Tomoko Arakawa1, Yumi Nishiguchi2, Masayo Hashimoto3
1Clinical Bioanalytics Group, Clinical Pharmacology and Bioanalytics, Pfizer R&D Japan G.K., Shibuya-ku, Tokyo, Japan.
Bioanalysis
|October 19, 2023
概括
第14届日本生物分析论坛研讨会召集了专家,以推动药物开发. 关键话题包括生物分析,新方法和以患者为中心的采样,以更快地提供药物.
科学领域:
- 生物分析是一种生物分析.
- 制药科学 制药科学
- 药物开发 药物开发
背景情况:
- 第14届日本生物分析论坛研讨会于2023年3月举行.
- 这次活动标志着四年来第一个在线选项的面对面研讨会,促进了合作.
研究的目的:
- 汇集来自生物分析不同领域的专家.
- 促进学习和合作,以加快向患者提供药物的速度.
主要方法:
- 一个混合的研讨会格式,结合了面对面和在线参与.
- 演讲和讨论涵盖了广泛的生物分析主题.
主要成果:
- 来自行业,学术界和监管机构的约360名参与者出席了会议.
- 讨论涵盖了关键领域,如ICH M10指南,新模式,生物标志物,免疫性,电子化和以患者为中心的采样.
结论:
- 研讨会成功促进了生物分析领域的跨学科合作.
- 生物分析技术和监管科学方面的进展被分享,以加快药物开发.
相关概念视频
Bioavailability: Overview
2.8K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.8K
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
174
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
174
Mass Spectrometry: Overview
5.3K
Mass spectrometry is an analytical technique used to determine the molecular mass and molecular formula of a compound. The basic principle of mass spectrometry is to generate ions from the analyte molecule and measure these ion abundances against their molecular mass. One common type of ionization, known as electrospray ionization or EI, bombards the analyte molecules in the gas phase with high-energy electron beams. The electron beams displace an electron from the molecule and leave...
5.3K
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K


